lobbying_filings_raw: 35b12620-e4e7-49ca-82da-61d16696a26e
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35b12620-e4e7-49ca-82da-61d16696a26e | YY | 74556 | JAMES P. KEESE | 167498 | TEVA PHARMACEUTICALS USA | 2004 | year_end | 2005-02-14T00:00:00-05:00 | 80000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/35b12620-e4e7-49ca-82da-61d16696a26e/", "filing_uuid": "35b12620-e4e7-49ca-82da-61d16696a26e", "filing_type": "YY", "filing_type_display": "Year-End Report", "filing_year": 2004, "filing_period": "year_end", "filing_period_display": "Year-End (July 1 - Dec 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/35b12620-e4e7-49ca-82da-61d16696a26e/print/", "filing_document_content_type": "application/pdf", "income": "80000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": null, "dt_posted": "2005-02-14T00:00:00-05:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": "United States of America", "registrant_address_1": null, "registrant_address_2": null, "registrant_different_address": null, "registrant_city": null, "registrant_state": null, "registrant_zip": null, "registrant": {"id": 74556, "url": "https://lda.senate.gov/api/v1/registrants/74556/", "house_registrant_id": 36042, "name": "JAMES P. KEESE", "description": "Government Affairs Consulting", "address_1": "444 North Capitol Street, NW", "address_2": "Suite 840", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20001", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "SHANNON BAIRD", "contact_telephone": "+1 703-477-3310", "dt_updated": "2026-01-30T19:35:24.801281-05:00"}, "client": {"id": 167498, "url": "https://lda.senate.gov/api/v1/clients/167498/", "client_id": 12, "name": "TEVA PHARMACEUTICALS USA", "general_description": null, "client_government_entity": false, "client_self_select": false, "state": "PA", "state_display": "Pennsylvania", "country": "US", "country_display": "United States of America", "ppb_state": "PA", "ppb_state_display": "Pennsylvania", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-08-06"}, "lobbying_activities": [{"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "S. 2493 Safe Import Act of 2004, all provisions.\r\nS. 2328 Pharmaceutical Market Access and Drug Safety Act of 2004, all provisions\r\ns. 2307 Reliable Entry for Medicines at Everyday Discounts through Importation with Effective Safeguards Act of 2004, all provisions.\r\nS. 666 Biological Chemical and Radiological Countermeasures Research Act, all provisions.\r\n", "foreign_entity_issues": null, "lobbyists": [{"lobbyist": {"id": 47013, "prefix": "mr", "prefix_display": "MR.", "first_name": "JAMES", "nickname": null, "middle_name": "P", "last_name": "KEESE", "suffix": null, "suffix_display": null}, "covered_position": "N/A", "new": null}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "TRD", "general_issue_code_display": "Trade (domestic/foreign)", "description": "United States Trade Representatives 301 Report.", "foreign_entity_issues": null, "lobbyists": [{"lobbyist": {"id": 47013, "prefix": "mr", "prefix_display": "MR.", "first_name": "JAMES", "nickname": null, "middle_name": "P", "last_name": "KEESE", "suffix": null, "suffix_display": null}, "covered_position": "N/A", "new": null}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Medicare Modernization Action of 2003; Title IX Access to Affordable Pharmaceuticals and Title VI Demonstration Project for Coverage of Certain Prescription Drugs and Biologicals", "foreign_entity_issues": null, "lobbyists": [{"lobbyist": {"id": 47013, "prefix": "mr", "prefix_display": "MR.", "first_name": "JAMES", "nickname": null, "middle_name": "P", "last_name": "KEESE", "suffix": null, "suffix_display": null}, "covered_position": "N/A", "new": null}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | DC | US | 36042 | PA | PA | US | US | 0 | 0 | 2060118 | normalized_name | 0.7 |